1120-95-2 | 3-Chloropyridazine

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$217.00	$152.00
5g	98%	in stock	$619.00	$433.00
10g	98%	in stock	$1,022.00	$716.00
25g	98%	in stock	$1,527.00	$1,069.00

Description

• Catalog Number: AB44543
• Chemical Name: 3-Chloropyridazine
• CAS Number: 1120-95-2
• Molecular Formula: C4H3ClN2
• Molecular Weight: 114.533
• MDL Number: MFCD06801356
• SMILES: Clc1cccnn1

Computed Properties

• Complexity: 57.7
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 7
• Hydrogen Bond Acceptor Count: 2
• XLogP3: 0.1

Literature

• 6-Chloro-N-(2-meth-oxy-phen-yl)pyridazin-3-amine.

  Acta crystallographica. Section E, Structure reports online 20120201

• Pharmacophore-based design, synthesis, and biological evaluation of novel chloro-pyridazine piperazines as human rhinovirus (HRV-3) inhibitors.

  Bioorganic & medicinal chemistry letters 20110201

• 3-Chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridazine.

  Acta crystallographica. Section E, Structure reports online 20101001

• Gram-scale synthesis of the p38α MAPK-inhibitor VX-745 for preclinical studies into Werner syndrome.

  Future medicinal chemistry 20100901

• 3-Chloro-6-{4-[3-(trifluoro-meth-yl)phen-yl]piperazin-1-yl}pyridazine.

  Acta crystallographica. Section E, Structure reports online 20100301

• 3-Chloro-6-[4-(2-pyrid-yl)piperazin-1-yl]pyridazine.

  Acta crystallographica. Section E, Structure reports online 20100101

• Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors.

  Bioorganic & medicinal chemistry 20090115

• Screening and evaluation of antioxidant activity of some pyridazine derivatives.

  Journal of enzyme inhibition and medicinal chemistry 20080401

• Synthesis of a new scaffold: the 7H,8H-pyrimido[1,6-b]pyridazin-6,8-dione nucleus.

  Molecules (Basel, Switzerland) 20071230

• An efficient synthesis and reactions of novel indolylpyridazinone derivatives with expected biological activity.

  Molecules (Basel, Switzerland) 20070110

• Docking of 6-chloropyridazin-3-yl derivatives active on nicotinic acetylcholine receptors into molluscan acetylcholine binding protein (AChBP).

  Farmaco (Societa chimica italiana : 1989) 20050401

• Solid-phase syntheses of 6-arylpyridazin-3(2H)-ones.

  Journal of combinatorial chemistry 20050101

• 6-Chloropyridazin-3-yl derivatives active as nicotinic agents: synthesis, binding, and modeling studies.

  Journal of medicinal chemistry 20020829